List of LabVantage SDMS Customers
High Wycombe, HP12 3SY,
United Kingdom
Since 2010, our global team of researchers has been studying LabVantage SDMS customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased LabVantage SDMS for Laboratory Management from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using LabVantage SDMS for Laboratory Management include: Maple Leaf Foods, a Canada based Consumer Packaged Goods organisation with 14000 employees and revenues of $4.95 billion, Novozymes, a Denmark based Oil, Gas and Chemicals organisation with 6397 employees and revenues of $2.57 billion, Oxford Biomedica, a United Kingdom based Life Sciences organisation with 850 employees and revenues of $165.0 million and many others.
Contact us if you need a completed and verified list of companies using LabVantage SDMS, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The LabVantage SDMS customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Maple Leaf Foods | Consumer Packaged Goods | 14000 | $5.0B | Canada | LabVantage Solutions | LabVantage SDMS | Laboratory Management | 2018 | n/a |
In 2018, Maple Leaf Foods implemented LabVantage SDMS to digitize food-safety and QA/QC workflows across multiple Canadian plants. LabVantage SDMS was positioned within the company Laboratory Management efforts to centralize instrument outputs and analytical files for traceability and regulatory compliance.
The deployment leveraged the integrated LabVantage suite combining LIMS, ELN, and SDMS capabilities, enabling document capture, instrument file management, and linkage of electronic records to laboratory test results. Configuration emphasized instrument data management, analytical file ingestion, automated sample tracking, and QA approval workflows to reduce manual handoffs and standardize laboratory procedures.
Operational coverage included quality and food-safety laboratories across several Canadian sites, with governance focused on centralized document control, audit trail visibility, and standardized data capture across plants. The implementation aimed to reduce paperwork and improve data visibility and productivity, with the LabVantage SDMS serving as the central laboratory management component for Maple Leaf Foods' QA and compliance processes.
|
 |
Novozymes | Oil, Gas and Chemicals | 6397 | $2.6B | Denmark | LabVantage Solutions | LabVantage SDMS | Laboratory Management | 2004 | n/a |
In 2004, Novozymes implemented LabVantage SDMS to centralize instrument file storage and test data across its laboratory estate. Novozymes has used LabVantage LIMS since the mid-2000s to manage global enzyme and assay data, and the SDMS adoption is inferred from subsequent LabVantage platform upgrades and managed-services engagements that extended the Laboratory Management footprint.
The LabVantage SDMS implementation focused on centralized storage and retrieval of instrument files and test data, aligning with common Laboratory Management workflows for metadata indexing, searchable archival, file versioning, and controlled access. Configuration work emphasized integration points with the existing LabVantage LIMS instances and the platform upgrades that governed file lifecycle and traceability across assay pipelines.
Integrations were implemented with SAP and multiple regional MRP systems to surface laboratory results into wider operational systems, supporting quality and production planning workflows. Operational coverage extended across Novozymes global labs, enabling consistent test data availability for research, development, and quality functions and providing a single repository for instrument-generated files.
Governance and rollout leveraged managed-services engagements to standardize data access policies, retention rules, and audit trail practices across sites. The integrated LabVantage LIMS and LabVantage SDMS environment supported improved Quality Management and operational availability as part of Novozymes broader Laboratory Management strategy.
|
 |
Oxford Biomedica | Life Sciences | 850 | $165M | United Kingdom | LabVantage Solutions | LabVantage SDMS | Laboratory Management | 2022 | n/a |
In 2022, Oxford Biomedica implemented LabVantage SDMS as part of LabVantage's integrated laboratory informatics platform to standardize QC and reduce paper based workflows across its UK cell and gene therapy laboratories. The LabVantage SDMS deployment was positioned within the Laboratory Management environment to support quality control, sample throughput, and end to end traceability for regulated and R&D activities.
The implementation encompassed the integrated LIMS, ELN, and SDMS modules of the LabVantage platform, with configuration focused on sample management, QC test workflows, electronic lab notebooks, instrument data capture, report generation, and audit trail capabilities. LabVantage SDMS was used to centralize instrument outputs and documentation, aligning electronic records with established QC procedures and laboratory execution workflows.
Operational scope covered Oxford Biomedica's UK cell and gene therapy labs, where the platform supported regulatory oriented record keeping and R&D laboratory workflows. The deployment consolidated instrument data and standardized reporting to improve downstream traceability of samples and test results across sites in the region.
Governance changes accompanied the technical rollout, with process standardization to replace paper based QC practices and to enforce electronic data capture and records retention. Outcomes reported include improved sample throughput and enhanced traceability, reflecting the platform driven shift toward centralized Laboratory Management and controlled QC operations.
|
Buyer Intent: Companies Evaluating LabVantage SDMS
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||